1. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00
  2. 23 Jan 2013  |  North America  |  Market Research

    Analysis of the European HIV Drugs Market

    Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

    Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

    $4,950.00